Department of Clinical Pharmacology and Pharmacoepidemiology, Medizinische Klinik (Krehl-Klinik), University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Drug Saf. 2013 Jan;36(1):31-41. doi: 10.1007/s40264-012-0007-5.
Numerous characteristics of a medication regimen can weaken patient adherence to drug therapy and thus impair clinical outcomes of drug therapy.
The aim of the study was to investigate the prevalence of medication regimen characteristics that are known to reduce patient adherence to drug therapy. Furthermore, we assessed to what extent complex medication regimens can possibly be simplified through different strategies.
We retrospectively evaluated the medication regimens of 500 consecutive patients discharged from the University Hospital of Heidelberg, Germany, in whom the dosages of all drugs were specified. The medication regimens were extracted from the discharge letters issued between 1 January 2007 and 29 December 2007. Each medication regimen was checked for the presence of seven regimen characteristics that are known to reduce patient adherence, and theoretical viable strategies to avoid four of the respective characteristics were identified. The extent of possible simplification through the identified strategies was evaluated for the overall study population and the subgroup of elderly patients (≥65 years) with polypharmacy (≥5 drugs).
On average, every medication regimen in the overall study population had 2.9±1.7 (standard deviation) characteristics (range 0-7) known to impair patient adherence. In contrast, the medication regimens of elderly patients with polypharmacy contained 3.7±1.6 characteristics (range 0-7) known to impair patient adherence. The most prevalent complexity characteristics in the overall study population were prescription of ≥1 drug with multiple doses per day (441 patients), ≥3 drugs with different dosing intervals (349 patients), tablet splitting (223 patients), followed by ≥12 daily drug administrations (190 patients). Almost half of the prescribed tablet splitting could be prevented. Moreover, 17.9% of the multi-dose prescriptions could be switched to once-daily dosing, and thus reduced the number of drugs with different dosing intervals and the number of daily drug administrations. The combined intervention reduced the total number of potentially preventable complexity characteristics by 18.3% (from 2283 to 1865 characteristics) without reducing prescription quality.
Almost one-fifth of all regimen complexity characteristics relevant for patient adherence were avoidable by simple modifications of the medication scheme, stressing the need for targeted interventions.
药物治疗方案的诸多特征会削弱患者对药物治疗的依从性,从而影响药物治疗的临床效果。
本研究旨在调查已知会降低患者药物治疗依从性的药物治疗方案特征的流行程度。此外,我们评估了通过不同策略使复杂的药物治疗方案尽可能简化的程度。
我们回顾性评估了 500 例连续出院患者的药物治疗方案,这些患者均来自德国海德堡大学医院,所有药物的剂量均有明确规定。治疗方案是从 2007 年 1 月 1 日至 2007 年 12 月 29 日期间开具的出院小结中提取的。对每种药物治疗方案进行检查,以确定存在已知会降低患者依从性的 7 种治疗方案特征,并确定了避免其中 4 种特征的理论可行策略。对总体研究人群和患有多种药物治疗(≥5 种药物)的老年患者(≥65 岁)亚组,通过确定的策略来简化治疗方案的程度进行了评估。
总体研究人群中,每种药物治疗方案平均有 2.9±1.7(标准差)个已知会降低患者依从性的特征(范围 0-7)。相比之下,患有多种药物治疗的老年患者的药物治疗方案中,有 3.7±1.6 个已知会降低患者依从性的特征(范围 0-7)。在总体研究人群中,最常见的复杂性特征是每天服用≥1 种多剂量药物(441 例)、不同剂量间隔服用≥3 种药物(349 例)、药片掰开服用(223 例),其次是每天服用≥12 种药物(190 例)。几乎一半的处方要求的药片掰开可以避免。此外,17.9%的多剂量处方可改为每日一次给药,从而减少了不同剂量间隔的药物和每日药物给药次数。综合干预措施使潜在可预防的复杂性特征总数减少了 18.3%(从 2283 个特征减少到 1865 个特征),同时不降低处方质量。
通过简单修改药物方案,可以避免近五分之一与患者依从性相关的治疗方案复杂性特征,这凸显了有针对性的干预措施的必要性。